Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis

ABSTRACT Background Testing for targeting programmed death ligand 1 (PD‐L1) is standard of care for patients with newly diagnosed non‐small cell lung cancer (NSCLC) but is only approved for use with core biopsy specimens. Endobronchial ultrasound guided miniforceps biopsy (EBUS‐MFB) is an approach t...

Full description

Saved in:
Bibliographic Details
Main Authors: Max T. Wayne, Nathaniel G. Moulton, Cody Weimholt, Praveen Chenna, Alexander C. Chen
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.15502
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576768872022016
author Max T. Wayne
Nathaniel G. Moulton
Cody Weimholt
Praveen Chenna
Alexander C. Chen
author_facet Max T. Wayne
Nathaniel G. Moulton
Cody Weimholt
Praveen Chenna
Alexander C. Chen
author_sort Max T. Wayne
collection DOAJ
description ABSTRACT Background Testing for targeting programmed death ligand 1 (PD‐L1) is standard of care for patients with newly diagnosed non‐small cell lung cancer (NSCLC) but is only approved for use with core biopsy specimens. Endobronchial ultrasound guided miniforceps biopsy (EBUS‐MFB) is an approach to obtain core biopsy material but data assessing the ability of EBUS‐MFB to adequately test for PD‐L1 is lacking. We evaluate the feasibility of EBUS‐MFB to acquire adequate tissue for PD‐L1 testing and look to compare the quality of specimens between EBUS‐MFB and endobronchial ultrasound guided transbronchial needle aspiration (EBUS‐TBNA) using a standard method of tissue analysis. Methods Twenty patients with suspected non‐small cell lung cancer undergoing bronchoscopy were recruited for enrollment. For each patient with NSCLC diagnosed on rapid onsite pathology with EBUS‐TBNA, EBUS‐MFB was performed. PD‐L1 immunostaining was completed to assess for adequacy. A comparison of tissue collection was performed using the total surface area measured by digital imaging. Results Among 20 patients, 65% were male with a mean age of 66 years with a total procedure time of 50 min and an average of 14 biopsy passes per procedure. 15 (75%) patients were diagnosed with NSCLC, and PD‐L1 analysis was successfully performed in 12 of the 15 (80%). The mean total tissue area obtained by the MFB technique was 9.757 mm2 compared to 6.941 mm2 with TBNA (p = 0.427). Conclusion In this feasibility study, EBUS‐MFB was successful in performing PD‐L1 testing in 80% of patients with NSCLC.
format Article
id doaj-art-873455bf78b74888bbf55dfd8482f335
institution Kabale University
issn 1759-7706
1759-7714
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj-art-873455bf78b74888bbf55dfd8482f3352025-01-30T22:40:34ZengWileyThoracic Cancer1759-77061759-77142025-01-01162n/an/a10.1111/1759-7714.15502Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue AnalysisMax T. Wayne0Nathaniel G. Moulton1Cody Weimholt2Praveen Chenna3Alexander C. Chen4Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine University of Michigan Ann Arbor Michigan USADivision of Pulmonary and Critical Care, Department of Internal Medicine Washington University in St. Louis St Louis Missouri USADivision of Anatomic and Molecular Pathology Washington University School of Medicine St. Louis Missouri USADivision of Pulmonary and Critical Care, Department of Internal Medicine Washington University in St. Louis St Louis Missouri USADivision of Pulmonary and Critical Care, Department of Internal Medicine Washington University in St. Louis St Louis Missouri USAABSTRACT Background Testing for targeting programmed death ligand 1 (PD‐L1) is standard of care for patients with newly diagnosed non‐small cell lung cancer (NSCLC) but is only approved for use with core biopsy specimens. Endobronchial ultrasound guided miniforceps biopsy (EBUS‐MFB) is an approach to obtain core biopsy material but data assessing the ability of EBUS‐MFB to adequately test for PD‐L1 is lacking. We evaluate the feasibility of EBUS‐MFB to acquire adequate tissue for PD‐L1 testing and look to compare the quality of specimens between EBUS‐MFB and endobronchial ultrasound guided transbronchial needle aspiration (EBUS‐TBNA) using a standard method of tissue analysis. Methods Twenty patients with suspected non‐small cell lung cancer undergoing bronchoscopy were recruited for enrollment. For each patient with NSCLC diagnosed on rapid onsite pathology with EBUS‐TBNA, EBUS‐MFB was performed. PD‐L1 immunostaining was completed to assess for adequacy. A comparison of tissue collection was performed using the total surface area measured by digital imaging. Results Among 20 patients, 65% were male with a mean age of 66 years with a total procedure time of 50 min and an average of 14 biopsy passes per procedure. 15 (75%) patients were diagnosed with NSCLC, and PD‐L1 analysis was successfully performed in 12 of the 15 (80%). The mean total tissue area obtained by the MFB technique was 9.757 mm2 compared to 6.941 mm2 with TBNA (p = 0.427). Conclusion In this feasibility study, EBUS‐MFB was successful in performing PD‐L1 testing in 80% of patients with NSCLC.https://doi.org/10.1111/1759-7714.15502biopsybronchoscopycytopathologynon‐small cell lung cancerPD‐L1
spellingShingle Max T. Wayne
Nathaniel G. Moulton
Cody Weimholt
Praveen Chenna
Alexander C. Chen
Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
Thoracic Cancer
biopsy
bronchoscopy
cytopathology
non‐small cell lung cancer
PD‐L1
title Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
title_full Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
title_fullStr Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
title_full_unstemmed Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
title_short Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
title_sort feasibility of endobronchial ultrasound guided miniforceps biopsy for pd l1 expression and quantitative tissue analysis
topic biopsy
bronchoscopy
cytopathology
non‐small cell lung cancer
PD‐L1
url https://doi.org/10.1111/1759-7714.15502
work_keys_str_mv AT maxtwayne feasibilityofendobronchialultrasoundguidedminiforcepsbiopsyforpdl1expressionandquantitativetissueanalysis
AT nathanielgmoulton feasibilityofendobronchialultrasoundguidedminiforcepsbiopsyforpdl1expressionandquantitativetissueanalysis
AT codyweimholt feasibilityofendobronchialultrasoundguidedminiforcepsbiopsyforpdl1expressionandquantitativetissueanalysis
AT praveenchenna feasibilityofendobronchialultrasoundguidedminiforcepsbiopsyforpdl1expressionandquantitativetissueanalysis
AT alexandercchen feasibilityofendobronchialultrasoundguidedminiforcepsbiopsyforpdl1expressionandquantitativetissueanalysis